SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001703057-23-000011
Filing Date
2023-05-24
Accepted
2023-05-24 14:36:22
Documents
18
Period of Report
2023-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20230524.htm   iXBRL 8-K 39614
2 EX-99.1 a991prexhibit.htm EX-99.1 12227
6 a991prexhibit001.jpg GRAPHIC 124346
7 a991prexhibit002.jpg GRAPHIC 218449
8 a991prexhibit003.jpg GRAPHIC 214699
9 a991prexhibit004.jpg GRAPHIC 182136
10 a991prexhibit005.jpg GRAPHIC 31309
  Complete submission text file 0001703057-23-000011.txt   1252743

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20230524.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20230524_lab.xml EX-101.LAB 22783
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20230524_pre.xml EX-101.PRE 11960
12 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20230524_htm.xml XML 10711
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 23953508
SIC: 2834 Pharmaceutical Preparations